top of page

In The Press

NovelStem Announces Material Developments and Strategic Repositioning of the Company

May 20

Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise

Jul 13, 2023

NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...

May 15, 2023

NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device

Dec 14, 2022

NovelStem Reports Third Quarter Results on Form 10-Q

Nov 14, 2022

NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...

Oct 13, 2022

NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary

Apr 11, 2022

NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

Feb 15, 2022

NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...

Sep 28, 2021

NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator

Sep 20, 2021

NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...

Dec 1, 2020

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...

Apr 21, 2020

NovelStem Provides Shareholder Update

Dec 16, 2019

NovelStem Provides Shareholder Update

May 8, 2019

Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...

Sep 25, 2018

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...

Jul 16, 2018

bottom of page